FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37743511000001106: Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
425521000001114 Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
425541000001116 Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Is a Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has specific active ingredient Betamethasone valerate true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) 30 gram Has AMP True Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start